Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer center

International Journal of Gynecological Cancer

Volumn 16, Issue SUPPL. 1, 2006, Pages 18-24

  Board, R E ^a   Bruijns, C T P H ^b   Pronk, A E ^b   Ryder, W D J ^a   Wilkinson, P M ^a   Welch, R ^a   Shanks, J H ^a   Connolly, G ^a   Slade, R J ^a   Reynolds, K ^c   Kitchener, H C ^c   Jayson, G C ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

CA125; Ovarian cancer; Stage; Survival

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER CENTER; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CANCER CARE FACILITIES; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645354047     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00308.x     Document Type: Article

References (18)

1. Colombo N Guthrie D Chiari S et al. International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 2003 95 125 32.
2. Trimbos JB Parmar M Vergote I et al. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant Chemotherapy in Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003 95 105 12.
3. Hankinson SE Coldotz GA Hunter DJ. A prospective study of reproductive factors and risk of epithelial ovarian cancer. Cancer 1995 76 284 90.
4. Allen DG Heintz AP Touw FW. A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary. Eur J Gynaecol Oncol 1995 16 349 56.
5. Vergote I De Brabanter J Fyles A et al. Prognostic importance of degree of differentiation and cyst rupture in stage 1 invasive epithelial ovarian carcinoma. Lancet 2001 357 176 82.
6. Rustin GJ Nelstrop AE McClean P et al. Defining response of ovarian carcinoma to initial chemotherapy according to serum CA125. J Clin Oncol 1996 14 1545 51.
7. Rustin GJ Nelstrop AE Tuxen MK Lambert HE. Defining progression of ovarian carcinoma during follow up according to serum CA125: a North Thames Ovary Group Study. Ann Oncol 1996 7 361 4.
8. Kaplan EL Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958 53 457 81.
9. Peto R Pike MC Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977 35 1 39.
10. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc 1972 34 187 220.
11. Grambsch PM Therneau TM Fleming TR. Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics 1995 51 1469 82.
12. Ho CM Huang YJ Chen TC et al. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Gynecol Oncol 2004 94 197 203.
13. Sevelda P Schemper M Spona J. CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1989 161 1213 6.
14. Makar AP Kristensen GB Kaern J Bormer OP Abeler VM Trope CG. Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis. Obstet Gynecol 1992 79 1002 10.
15. Nagele F Petru E Medl M Kainz C Graf AH Sevelda P. Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1995 86 259 64.
16. Trimbos JB Vergote I Bolis G et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003 95 113 25.
17. Kolomainen DF A'Hern R Coxon FY et al. Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy? J Clin Oncol 2003 21 3113 8.
18. Zanetta G Rota S Chiari S et al. The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma. A multivariate analysis. Ann Oncol 1998 9 1097 101.